BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1253962)

  • 1. [Influence of octadine, reserpine and methyl-dopa on the hemodynamic system].
    Iuzhakov SD
    Farmakol Toksikol; 1976; 39(1):40-3. PubMed ID: 1253962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of reserpine, octadine and methyldopa on the distribution of cardiac output in hypertension].
    Iuzhakov SD
    Farmakol Toksikol; 1976; 39(5):562-5. PubMed ID: 1028583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Glezer GA
    Kardiologiia; 1968 Aug; 8(8):113-8. PubMed ID: 5727457
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of reserpine, guanethidine and methyldopa on general and regional hemodynamics].
    Iuzhakov SD; Kotliarov EV
    Farmakol Toksikol; 1973; 26(4):429-32. PubMed ID: 4789888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
    Uspenskiĭ AE; Korobov NV
    Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopegit in the treatment of hypertensive disease].
    Erina EV; Pershakova LP; Vasil'eva LA
    Kardiologiia; 1971 May; 11(5):96-104. PubMed ID: 5126325
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure.
    Roca-Cusachs A; DiPette DJ; Nickols GA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):110-8. PubMed ID: 1988652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I; Yuzhakov S
    Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of reserpine, isobarin and dopegit on the resistance of cerebral vessels].
    Beketov AI; Svistov VV; Tkachenko BI; Krasil'nikov VG
    Farmakol Toksikol; 1977; 40(2):162-6. PubMed ID: 856625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in systemic hemodynamics and vascular resistance in unilaterally nephrectomized rats with vasorenal hypertension].
    Kuznetsova LV; Storozhevykh TP; Pinelis VG; Sokolova IA; Markov KhM
    Patol Fiziol Eksp Ter; 1989; (1):32-6. PubMed ID: 2717229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A centrally mediated peripheral hypotensive effect of alpha-methyldopa.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1970 Dec; 175(3):593-9. PubMed ID: 5489916
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of long-term converting-enzyme inhibition in renal hypertensive rats.
    Salom MG; Salazar FJ; Fenoy FJ; Pinilla JM; Marín N; Quesada T
    Rev Esp Fisiol; 1990 Jun; 46(2):171-6. PubMed ID: 2274701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance.
    Mohammed S; Gaffney TE; Yard AC; Gomez H
    J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
    Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
    Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depressive effect of total flavonoid fraction of Asttragalus complanatus R. Br and its influence upon hemodynamics in SHR].
    Xue B; Li JX; Chen LB
    Zhongguo Zhong Yao Za Zhi; 2002 Nov; 27(11):855-8. PubMed ID: 12776592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.